Atlas market file · Equity · United States
Gen Digital Inc.GEN
- Last close
- 28.1
- Change
- +0.54%
- 96-bar range
- 17.78 – 28.5
- As of
- 6 Aug 2026
Gen Digital Inc. is a services-prepackaged software issuer listed as GEN on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (+9.25% over the window).
Source rail: Yahoo Finance chart API (GEN). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for GEN. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
Atlas Pro artifact
GEN Market Snapshot PDF
The latest snapshot audit passed. Atlas checks entitlement and evidence again when the PDF is requested.
Atlas Pro entitlement required. The release gate runs again when you request the file.
GEN public profile
Services-prepackaged software issuer. Gen Digital Inc. is connected to current market context, cited company sources and its retained research file.
Gen Digital Inc. trades as GEN on NASDAQ. Gen Digital Inc. (GEN) has a latest verified close of 28.1, up 0.54%, dated 6 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files GEN under USA Stocks and Technology Stocks for browsing.
What changed for Gen Digital Inc. today
Gen Digital Inc. (GEN) reported $5 billion in revenue for the fiscal year ending April 2026, driven by a $823 million boost from its MoneyLion acquisition and $87 million from favorable currency impacts. Net income hit $973 million, though liabilities swelled to $12.98 billion against $15.59 billion in total assets, leaving equity at just $2.61 billion. (source: SEC EDGAR 10-K)
The company’s ‘Cyber Safety Platform’ and ‘Trust-Based Solutions’ now account for the bulk of sales, but reliance on indirect channels - distributors, resellers, and telecom partners - exposes Gen to partner risk. Its ‘AI agent’ product, pitched as organizing family logistics via the Gen Trust Hub, remains unproven at scale. (source: Press Release, https://newsroom.gendigital.com/press-releases)
Free cash flow reached $1.54 billion, but capital expenditures were just $22 million, suggesting minimal reinvestment. Research and development costs ate $409 million, while insider sales have accelerated in June, with multiple executives offloading shares worth millions. (source: SEC EDGAR Form 4 filings)
Gen’s financial services partnerships aim to embed scam protection and identity tools into client platforms, though customer retention remains a question: the 10-K explicitly warns users can cancel ‘at any time.’ (source: Financial Services, https://www.gendigital.com/us/en/partner/financial-services/)
Fiscal 2027 guidance will arrive August 6, but the current evidence shows a company still digesting acquisitions while burning through cash reserves ($1.01 billion as of March 2025). The stock’s diluted share count now exceeds 619 million, raising dilution concerns. (source: SEC EDGAR 10-K)
Sources & evidence · 10 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
GEN technical readout
Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on GEN
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep GEN research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
GEN FAQ
What is Gen Digital Inc. (GEN)?Gen Digital Inc. (GEN) has a latest verified close of 28.1, up 0.54%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates,...
Gen Digital Inc. (GEN) has a latest verified close of 28.1, up 0.54%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for GEN?Gen Digital Inc. (GEN) has a latest verified close of 28.1, up 0.54%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and...
Gen Digital Inc. (GEN) has a latest verified close of 28.1, up 0.54%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files GEN under USA Stocks and Technology Stocks for browsing.
How often is the GEN page updated?The GEN public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The GEN public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for GEN?The GEN file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:GEN. SEC EDGAR provides the filing anchor for this issuer. The page separates verified...
The GEN file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:GEN. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on GEN?Yes. The workstation can open GEN, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open GEN, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this GEN page investment advice?No. The GEN page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The GEN page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
GEN
Equity · evidence first